Evofem Biosciences, Inc. (EVFM) › Total LiabilitiesEvofem Biosciences, Inc. (EVFM) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2017: $103.63M2018: $27.37M2019: $12.66M2020: $108.62M2021: $142.09M2022: $96.96M2023: $72.47M2024: $90.26M2025: $89.71M$89.71M2017Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$89.71M-0.6%2024$90.26M+24.6%2023$72.47M-25.3%2022$96.96M-31.8%2021$142.09M+30.8%2020$108.62M+758.1%2019$12.66M-53.7%2018$27.37M-73.6%2017$103.63M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share